Anti-Cancer Effects of Erlotinib (EGFR Inhibitor) on Metastasis of Breast Cancer Cell Lines
Multidisciplinary Cancer Investigation
doi 10.21859/mci-supp-59
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
Definitive International Institute of Life Science (DIILI Publication)